Daito Pharmaceutical Co.,Ltd.
4577.T · JPX
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | ¥36,942,817 | ¥29,965,401 | ¥15,390,733 | ¥16,065,384 |
| - Cash | ¥2,149,000 | ¥2,207,000 | ¥2,379,000 | ¥3,241,000 |
| + Debt | ¥11,938,000 | ¥11,885,000 | ¥10,493,000 | ¥11,318,000 |
| Enterprise Value | ¥46,731,817 | ¥39,643,401 | ¥23,504,733 | ¥24,142,384 |
| Revenue | ¥13,011,000 | ¥14,034,000 | ¥12,025,000 | ¥11,906,000 |
| % Growth | -7.3% | 16.7% | 1% | – |
| Gross Profit | ¥2,558,000 | ¥2,262,000 | ¥1,997,000 | ¥2,129,000 |
| % Margin | 19.7% | 16.1% | 16.6% | 17.9% |
| EBITDA | ¥2,083,000 | ¥1,697,000 | ¥1,668,000 | ¥1,673,500 |
| % Margin | 16% | 12.1% | 13.9% | 14.1% |
| Net Income | ¥696,000 | ¥691,000 | ¥309,000 | ¥291,000 |
| % Margin | 5.3% | 4.9% | 2.6% | 2.4% |
| EPS Diluted | 23.21 | 22.71 | 20.33 | 18.96 |
| % Growth | 2.2% | 11.7% | 7.2% | – |
| Operating Cash Flow | ¥0 | ¥0 | ¥0 | ¥920,000 |
| Capital Expenditures | ¥0 | ¥0 | ¥0 | -¥2,444,000 |
| Free Cash Flow | ¥0 | ¥0 | ¥0 | -¥1,524,000 |